We are live on ! Find out more
ATRS

Antares Pharma, Inc.

Delisted

ATRS was delisted on the 23rd of May, 2022.

1 hedge funds and large institutions have $12K invested in Antares Pharma, Inc. in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 1771 (-176)

100% less funds holding in top 10

Funds holding in top 10: 40 (-4)

100% less capital invested

Capital invested by funds: $375M → $12K (-$375M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 172

Holders
1
Holders Change
-176
Holders Change %
-99.44%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
172
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
101
Royal Bank of Canada
Ontario, Canada
-$179K -43,856 Closed
ASRS
102
Arizona State Retirement System
Arizona
-$179K -43,667 Closed
DCM
103
Dupont Capital Management
Delaware
-$170K -41,419 Closed
Carson Wealth (CWM LLC)
104
Carson Wealth (CWM LLC)
Nebraska
-$153K -37,292 Closed
CHAM
105
Clear Harbor Asset Management
Connecticut
-$149K -36,400 Closed
Jane Street
106
Jane Street
New York
-$149K -36,284 Closed
Teacher Retirement System of Texas
107
Teacher Retirement System of Texas
Texas
-$136K -33,238 Closed
DT
108
Diversified Trust
Tennessee
-$136K -33,236 Closed
Janus Henderson Group
109
Janus Henderson Group
United Kingdom
-$131K -32,202 Closed
ProShare Advisors
110
ProShare Advisors
Maryland
-$129K -31,299 Closed
Rafferty Asset Management
111
Rafferty Asset Management
New York
-$124K -30,358 Closed
JLBC
112
J.L. Bainbridge & Co
Florida
-$123K -30,000 Closed
EGM
113
Engineers Gate Manager
New York
-$122K -29,697 Closed
LPL Financial
114
LPL Financial
California
-$117K -28,420 Closed
AB
115
Amalgamated Bank
New York
-$111K -27,177 Closed
XT
116
XTX Topco
Cayman Islands
-$106K -25,751 Closed
Simplex Trading
117
Simplex Trading
Illinois
-$104K -25,514 Closed
LA
118
LVW Advisors
New York
-$103K -25,000 Closed
AC
119
AlphaCore Capital
California
-$97K -23,621 Closed
Citigroup
120
Citigroup
New York
-$94K -22,867 Closed
HighTower Advisors
121
HighTower Advisors
Illinois
-$86K -21,035 Closed
Lazard Asset Management
122
Lazard Asset Management
New York
-$84K -20,567 Closed
HSBC Holdings
123
HSBC Holdings
United Kingdom
-$85K -20,551 Closed
BTWM
124
Baker Tilly Wealth Management
Wisconsin
-$83K -20,201 Closed
Envestnet Asset Management
125
Envestnet Asset Management
Illinois
-$79K -19,231 Closed

ATRS Hedge Fund Activity: Q2 2022 in Review

1 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q2 2022, worth a combined $12K — down 100% from $375M a quarter earlier.

Sellers outnumbered buyers: 172 funds closed out of ATRS and 0 opened new positions — a net loss of 172 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $49M sold.

  • 1 institutional investor held Antares Pharma, Inc. (ATRS) as of Q2 2022, down from 177 in Q1 2022.
  • Funds reported $12K of Antares Pharma, Inc. stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Antares Pharma, Inc. positions in Q2 2022 and 172 closed out, a net change of -172 holders.
  • The largest Antares Pharma, Inc. seller in Q2 2022 was BlackRock, an estimated $49M sold.

Based on aggregated 13F filings for Q2 2022.